Cite
APA Citation
Bauman, J., Burris, H., Clarke, J., Patel, M., Cho, D., Gutierrez, M., Julian, R., Scott, A., Cohen, P., Frederick, J., Robert-Tissot, C., Zhou, H., Mody, K., Keating, K., Meehan, R., & Gainor, J. (n.d.). 798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update. Journal for immunotherapy of cancer, 8, A477. http://access.bl.uk/ark:/81055/vdc_100144722043.0x000003